Zeng, S., Yan, Q., Yang, L., Mei, Q., & Lu, H. (2020). Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2. Mediators Inflamm.
Citação norma ChicagoZeng, Si-yu, Qiu-jiang Yan, Li Yang, Qing-hua Mei, and Hui-qin Lu. "Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy Via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2." Mediators Inflamm 2020.
MLA citiranjeZeng, Si-yu, et al. "Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy Via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2." Mediators Inflamm 2020.